Teva Pharmaceuticals

In accordance with the Vermont Pharmaceutical Marketer Price Disclosure Law (18 V.S.A. Section 4633), Teva is disclosing certain required pricing information to individuals authorized to prescribe prescription drugs in Vermont.

Please choose a product from the list, and select either “Long form” or “Short form” below:

AUSTEDO® (deutetrabenazine) Tablets Long Form Short Form
AUSTEDO® XR (deutetrabenazine) extended-release Tablets Long Form Short Form


Please click here to see full prescribing information, including any BOXED WARNINGS, for the product(s) listed above.

The prescribing information approved by the U.S. Food and Drug Administration must continue to guide appropriate use of Teva medicines. The intent of this website is only to provide pricing information to individuals licensed to prescribe drugs by the State of Vermont in accordance with Vermont's law. For more detailed information or healthcare advice, members of the public should consult healthcare professionals.